Dipòsit Digital de Documents de la UAB 1 registres trobats  La cerca s'ha fet en 0.01 segons. 
10 p, 595.1 KB Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma / Wick, Antje (Heidelberg University Medical Center) ; Desjardins, Annick (Duke University. The Preston Robert Tisch Brain Tumor Center at Duke) ; Suarez, Cristina (Vall d'Hebron Institut d'Oncologia) ; Forsyth, Peter (H. Lee Moffitt Cancer Center and Research Institute) ; Gueorguieva, Ivelina (Eli Lilly and Company) ; Burkholder, Tiana (Eli Lilly and Company) ; Cleverly, Ann Louise (Eli Lilly and Company) ; Estrem, Shawn T. (Eli Lilly and Company) ; Wang, Shuaicheng (BioStat Solutions (Estats Units)) ; Lahn, Michael M. (Eli Lilly and Company) ; Guba, Susan C. (Eli Lilly and Company) ; Capper, David (Universitätsmedizin Berlin) ; Rodon Ahnert, Jordi (Vall d'Hebron Institut d'Oncologia) ; Universitat Autònoma de Barcelona
The online version of this article contains supplementary material, which is available to authorized users.
2020 - 10.1007/s10637-020-00910-9
Investigational New Drugs, Vol. 38 (march 2020) , p. 1570-1579  

Vegeu també: autors amb noms similars
3 Wang, S.
218 Wang, S. M.
2 Wang, S. P.
1 Wang, S.A.
1 Wang, S.J.
18 Wang, S.M.
1 Wang, S.X.
1 Wang, Shanshan
1 Wang, Shijie
1 Wang, Shiping
2 Wang, Shiqi
1 Wang, Shu Hua
2 Wang, Shu-Hua
2 Wang, Shuai
1 Wang, Shutao
1 Wang, Shuu-Jiun
2 Wang, Sibo
1 Wang, Sichu
1 Wang, Songhan
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.